The PGY2 Investigational Drugs and Research Pharmacy residency program at UTSW is a one-year post-graduate training program designed to provide an opportunity for the residents to develop strong clinical foundation, knowledge, leadership skills and experience to specialize in clinical research and investigational drug services.

PGY2 pharmacy residency program will provide residents with opportunities to function as independent practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete the program will be prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program Requirements: Pharm.D., eligibility for Texas licensure, completion of ASHP accredited PGY-1 residency.  All application materials must be submitted via PhORCAS: Letter of intent, curriculum vitae, three letters of recommendation, and official transcripts from all pharmacy education

About UT Southwestern PGY2 Investigational Drugs and Research Pharmacy Residency

UT Southwestern Medical Center is a premier academic health system, with a top-ranked medical school and patient care services ranked as one of the best in the Dallas-Ft. Worth Metroplex, providing a full range of patient care. The growing health system contains 900 staffed beds and serves 37,000 inpatients annually. The Department of Pharmacy maintains academic relationships with many Colleges of Pharmacy and the UT Southwestern Medical School, ensuring a strong commitment to the education of pharmacy residents and students. The Department of Pharmacy supports over 650 therapeutic clinical trials in many disease states in the acute care, oncology and ambulatory clinical settings and infusion centers.

Connections working at UT Southwestern PGY2 Investigational Drugs and Research Pharmacy Residency